Go Premium in Our Biggest Sale Ever

Go Ultimate 75% OFF

BWAY Stock Latest News

Company AnnouncementsBrainsWay Investor Deck Details Q3 2026 Growth and Scale7h ago6K BWAY

The FlyBrainsway reports Q3 EPS 5c, consensus 9c12h agoBWAY
The FlyBrainsway backs FY26 revenue view $68M-$70M, consensus $69.16M12h agoBWAY
Company AnnouncementsBrainsWay Reports 34% Third-Quarter Revenue Growth to $18.1 Million15h ago6K BWAY
Pre-EarningsBrainsway (BWAY) Q3 Earnings Cheat Sheet2d agoBWAY

BrainsWay’s New Clinic Partnerships Support Growth Outlook; Buy Rating Reiterated with $19 Price Target Unchanged

RatingsBrainsWay’s New Clinic Partnerships Support Growth Outlook; Buy Rating Reiterated with $19 Price Target Unchanged1w agoBWAY

Company AnnouncementsBrainsWay Announces Strategic Collaboration With Mindful Health Solutions1w ago6K BWAY

The FlyBrainsway announces strategic collaboration with Mindful Health Solutions1w agoBWAY

RatingsBrainsWay: Buy Rating Reiterated as Deep TMS Coverage Expands; $19 Price Target Maintained1w agoBWAY
Company AnnouncementsBrainsWay Lifts Deep TMS OCD Insurance Coverage to Over 118 Million Americans2w ago6K BWAY
Company AnnouncementsBrainsWay Sets November 25, 2026 Annual Shareholder Meeting With Auditor, Board and Equity Votes2w ago6K BWAY
Company AnnouncementsBrainsWay Strikes Strategic Deep TMS Partnership With Southern California’s Inland Psychiatric Medical Group3w ago6K BWAY

Brainsway: Buy Rating Reaffirmed on Strategic Momentum and Reimbursement Expansion; 12‑Month Price Target Maintained at $19

RatingsBrainsway: Buy Rating Reaffirmed on Strategic Momentum and Reimbursement Expansion; 12‑Month Price Target Maintained at $193w agoBWAY

Company AnnouncementsBrainsWay Expands U.S. Coverage for SWIFT Deep TMS to Over 70 Million Lives4w ago6K BWAY

The FlyBrainsway reports rise in Swift Accelerated Deep TMS protocol coverage4w agoBWAY

Company AnnouncementsBrainsway Files Interim H1 2026 Financials with SEC1M ago6K BWAY
Company AnnouncementsBrainsWay Announces Strong Pilot Results for Deep TMS in Depression with Early-Stage Alzheimer’s2M ago6K BWAY
The FlyBrainsway publishes results from pilot study2M agoBWAY
The FlyBrainsway price target raised to $19 from $17 at H.C. Wainwright2M agoBWAY

BrainsWay Study Highlights 70% Drop in Suicidal Ideation With Deep TMS in MDD Patients

Company AnnouncementsBrainsWay Study Highlights 70% Drop in Suicidal Ideation With Deep TMS in MDD Patients2M ago6K BWAY

The FlyBrainsway reports Q2 EPS 7c, consensus 7c2M agoBWAY

The FlyBrainsway raises FY26 revenue view to $68M-$70M from $66M-$68M2M agoBWAY